| Unith Ltd (UNT) ORDINARY FULLY PAID |
Communication Services |
$12 |
Issue of Shares and Cleansing Notice
|
16 Jul 2025 9:16AM |
$0.007 |
$0.008 |
risen by
14.29%
|
|
| Alice Queen Limited (AQX) ORDINARY FULLY PAID |
Materials |
$15 |
Initial Director's Interest Notice
|
16 Jul 2025 9:15AM |
$0.004 |
$0.008 |
risen by
100%
|
|
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,241 |
Release of Shares from Voluntary Escrow
|
16 Jul 2025 9:15AM |
$0.036 |
$0.245 |
risen by
580.56%
|
|
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$406 |
Update - Notification of buy-back - RG8
|
16 Jul 2025 9:14AM |
$2.010 |
$2.830 |
risen by
40.80%
|
|
| Andean Silver Limited (ASL) ORDINARY FULLY PAID |
Materials |
$440 |
Trading Halt
|
16 Jul 2025 9:14AM |
$1.385 |
$2.070 |
risen by
49.46%
|
|
ASL - Price-sensitive ASX Announcement
Full Release
Key Points
- Andean Silver Limited requested a trading halt on 7 June 2023.
- The trading halt is due to a pending announcement about a material acquisition and proposed capital raising.
- The halt will remain until either the announcement is made or trading resumes on 9 June 2023.
- The company seeks to ensure orderly trading of its securities during this period.
- The trading halt request was sent to the Australian Securities Exchange (ASX).
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alice Queen Limited (AQX) ORDINARY FULLY PAID |
Materials |
$15 |
Final Director's Interest Notice
|
16 Jul 2025 9:12AM |
$0.004 |
$0.008 |
risen by
100%
|
|
| Scalare Partners Holdings Limited (SCP) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Suspension from Quotation
|
16 Jul 2025 9:11AM |
$0.170 |
$0.072 |
fallen by
57.65%
|
|
SCP - Price-sensitive ASX Announcement
Full Release
Key Points
- Scalare Partners Holdings Limited (SCP) requested a voluntary suspension from quotation on the ASX.
- The suspension is due to pending announcements about a capital raising and a proposed acquisition.
- The suspension will last until either the relevant announcements are made or trading resumes on 14 June 2024.
- The company is finalising the details of the capital raising and acquisition.
- SCP has assured shareholders it will provide further updates as soon as possible.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Unith Ltd (UNT) ORDINARY FULLY PAID |
Communication Services |
$12 |
Application for quotation of securities - UNT
|
16 Jul 2025 9:11AM |
$0.007 |
$0.008 |
risen by
14.29%
|
|
| Alliance Nickel Limited (AXN) ORDINARY FULLY PAID |
Materials |
$28 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
16 Jul 2025 9:10AM |
$0.035 |
$0.034 |
fallen by
2.86%
|
|
AXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed Definitive Feasibility Study (DFS) for the NiWest Nickel-Cobalt Project.
- Signed binding offtake and investment agreement with Stellantis N.V. for nickel and cobalt sulphate supply.
- Advanced project permitting, including submission of the Environmental Review Document.
- Initiated Front End Engineering Design (FEED) and commenced additional metallurgical and engineering work.
- Engaged with government, traditional owners, and stakeholders for project approvals and social license.
- Pursuing project financing and additional offtake agreements to support project execution.
- Reported cash and cash equivalents at the end of the quarter, outlining major cash outflows and inflows.
- Maintained active investor relations, including updates on market engagement and regulatory disclosures.
- Progressing toward a final investment decision for the NiWest Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alice Queen Limited (AQX) ORDINARY FULLY PAID |
Materials |
$15 |
Board Changes and Update
|
16 Jul 2025 9:09AM |
$0.004 |
$0.008 |
risen by
100%
|
|
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - VG1
|
16 Jul 2025 9:09AM |
$1.735 |
$1.950 |
risen by
12.39%
|
|
| Unith Ltd (UNT) ORDINARY FULLY PAID |
Communication Services |
$12 |
Notification of cessation of securities - UNT
|
16 Jul 2025 9:09AM |
$0.007 |
$0.008 |
risen by
14.29%
|
|
| Critica Limited (CRI) ORDINARY FULLY PAID |
Materials |
$67 |
Critica Advances Jupiter- Outstanding Magnet and HREO Grades
|
16 Jul 2025 9:08AM |
$0.017 |
$0.022 |
risen by
29.41%
|
|
CRI - Price-sensitive ASX Announcement
Full Release
Key Points
- Critica Limited announced outstanding MagREO and HREO grades from the Jupiter project in Northern Territory.
- New drilling expanded high-grade rare earth mineralization, confirming Jupiter's significance.
- Key drill results demonstrate high total rare earth oxide grades over broad intervals.
- Significant concentrations of neodymium, praseodymium, dysprosium, and terbium reported.
- Jupiter project positioned as one of Australia’s largest rare earth discoveries.
- Ongoing resource definition drilling and metallurgical studies planned.
- Results solidify Critica Limited’s role in the rare earth supply chain.
- Further drilling and studies will assess economic potential and development options.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prescient Therapeutics Limited (PTX) ORDINARY FULLY PAID |
Health Care |
$70 |
PTX Opens First U.S. Site for PTX-100 Phase 2a Trial
|
16 Jul 2025 9:08AM |
$0.042 |
$0.067 |
risen by
59.52%
|
|
PTX - Price-sensitive ASX Announcement
Full Release
Key Points
- Prescient Therapeutics Limited (PTX) has opened its first U.S. clinical site for the PTX-100 Phase 2a trial.
- PTX-100 is a novel inhibitor targeting geranylgeranyl transferase-1 (GGT-1).
- The Phase 2a trial focuses on patients with relapsed and refractory T cell lymphomas (PTCL and CTCL).
- Expansion into the U.S. enables broader patient access and collaboration with leading clinical centers.
- Previous trial cohorts showed promising efficacy and an encouraging safety profile.
- The initiative addresses unmet needs for patients with limited treatment options.
- PTX continues to advance innovation in cancer therapeutics through this clinical development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$23 |
Proposed issue of securities - DAL
|
16 Jul 2025 9:07AM |
$0.029 |
$0.071 |
risen by
144.83%
|
|
| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$23 |
Proposed issue of securities - DAL
|
16 Jul 2025 9:07AM |
$0.029 |
$0.071 |
risen by
144.83%
|
|
| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$23 |
Strategic Capital Raise With Cornerstone Support Completed
|
16 Jul 2025 9:07AM |
$0.029 |
$0.071 |
risen by
144.83%
|
|
DAL - Price-sensitive ASX Announcement
Full Release
Key Points
- Dalaroo Metals Ltd completed a $1.35 million capital raise at $0.045 per share.
- The raise was strongly supported by cornerstone investors and existing shareholders.
- Demand for the capital raise was significantly oversubscribed.
- Funds will be used for exploration at Browns Range, Lyons River, and Namban projects.
- The projects target critical minerals, including niobium, rare earth elements, and lithium.
- The company is actively reviewing further critical minerals project opportunities.
- Dalaroo expressed thanks to investors and reaffirmed its commitment to shareholder value.
- The announcement details the anticipated timeline for share issuance and new capital structure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$322 |
NTA at 11.07.25 Pre-tax 140.5 Post-tax 135.63
|
16 Jul 2025 9:05AM |
$1.205 |
$1.250 |
risen by
3.73%
|
|
| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$5 |
Notification of cessation of securities - WNX
|
16 Jul 2025 9:04AM |
$0.255 |
$0.070 |
fallen by
72.55%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$712 |
Update - Notification of buy-back - RF1
|
16 Jul 2025 9:03AM |
$2.990 |
$3.410 |
risen by
14.05%
|
|
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$71 |
Radiopharm Receives $4.5M R&D Tax Incentive
|
16 Jul 2025 9:01AM |
$0.022 |
$0.020 |
fallen by
9.09%
|
|
| Kingsgate Consolidated Limited (KCN) ORDINARY FULLY PAID |
Materials |
$1,562 |
Continued Exploration Success at the Chatree Gold Mine
|
16 Jul 2025 9:00AM |
$2.470 |
$5.870 |
risen by
137.65%
|
|
KCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Kingsgate Consolidated Limited reports continued exploration success at the Chatree Gold Mine.
- Recent drilling has delivered significant gold intersections and identified high-grade zones.
- These results are expected to increase resources, reserves, and potentially extend mine life.
- Active exploration is ongoing both near the mine and in regional targets.
- Refurbishment of the processing plant is progressing, supporting the restart of operations.
- The company is engaging with local communities and complying with regulatory requirements.
- Kingsgate remains optimistic about the long-term potential and growth of the Chatree Gold Mine.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vection Technologies Ltd (VR1) ORDINARY FULLY PAID |
Information Technology |
$60 |
Amendment - Vection Secures Further $0.5m Defence Order
|
16 Jul 2025 8:57AM |
$0.037 |
$0.026 |
fallen by
29.73%
|
|
VR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Vection Technologies Ltd secured a further $0.5 million order from a defence sector client.
- The order is related to advanced 3D and VR technology solutions.
- This announcement amends details from an earlier release.
- The contract underscores Vection’s role as a strategic partner for the defence customer.
- The new order reflects growing demand for Vection’s immersive technology.
- The company demonstrates ability to scale and secure repeat business with key clients.
- This development supports Vection Technologies Ltd’s ongoing growth in the defence sector.
- The company continues to strengthen relationships in the immersive technology and defence markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cyclopharm Limited (CYC) ORDINARY FULLY PAID |
Health Care |
$102 |
CYC Appoints US Sales Vice President
|
16 Jul 2025 8:56AM |
$0.990 |
$0.810 |
fallen by
18.18%
|
|
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$499 |
Update - Notification of buy-back - PE1
|
16 Jul 2025 8:55AM |
$1.175 |
$1.870 |
risen by
59.15%
|
|
Call 1300 880 160
Start a chat
Schedule a call
